MKI67 and neoplasm: The Ki-67 proliferation index, an important marker of tumor aggressiveness, was ≤2% in 27 (43.5%) patients, with the majority falling in the 1-2% range, specifically 19 (30.6%), indicating a predominance of well-differentiated, slow-growing tumors.